Regeneron Pharmaceuticals announced on Monday that it will acquire "substantially all" of genetic testing company 23andMe's assets. The pharmaceutical company said it won the court-supervised auction ...
If you're looking to uncover family history or learn more about your health, here's how to decide which DNA testing kit is ...
A court hearing to consider the transaction’s approval is scheduled for June 17, according to 23andMe Justin Sullivan/Getty; Michael Nagle/Bloomberg via Getty Genetics company 23andMe is expected to ...
Regeneron Pharmaceuticals acquiring genetic testing firm 23andMe for $256 million. The deal follows 23andMe’s Chapter 11 bankruptcy protection filing in March. Transaction excludes telehealth provider ...
Regeneron Pharmaceuticals on Monday announced it will acquire "substantially all" of 23andMe's assets for $256 million. Stream NBC 5 for free, 24/7, wherever you are. The drugmaker participated in a ...
Regeneron Pharmaceuticals, a biotechnology company with a long history of large-scale genetics research, plans to buy DNA testing firm 23andMe out of bankruptcy, announcing Monday it was named the ...
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection. In March 23andMe said that ...
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection. In March 23andMe said that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback